Five-grass pollen 300IR SLIT tablets: Efficacy and safety in children and adolescents

Pediatric Allergy and Immunology

Volumn 21, Issue 6, 2010, Pages 970-976

  Halken, Susanne ^a   Agertoft, Lone ^a   Seidenberg, Jürgen ^b   Bauer, Carl Peter ^c   Payot, Franois ^d   Martin Muñoz, Maria Flora ^e   Bartkowiak Emeryk, Małgorzata ^f   Vereda, Andrea ^g   Jean Alphonse, Stephanie ^g   Melac, Michel ^g   Le Gall, Martine ^g   Wahn, Ulrich ^h  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b KLINIKUM OLDENBURG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Private Office   (France)

^e HOSPITAL INFANTIL LA PAZ   (Spain)

^f MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^g Stallergenes SA   (France)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

adolescents; allergic rhinoconjunctivitis; children; grass pollen; sublingual immunotherapy tablets

Indexed keywords

GRASS POLLEN EXTRACT; PLACEBO;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; EPIPHORA; FEMALE; GRASS POLLEN; HAY FEVER; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MOUTH EDEMA; NASAL PRURITUS; NOSE CONGESTION; OCULAR PRURITUS; ORAL PRURITUS; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; RHINORRHEA; SCHOOL CHILD; SNEEZING;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; AGE FACTORS; ALLERGENS; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; EUROPE; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PATIENT SATISFACTION; POACEAE; RHINITIS, ALLERGIC, SEASONAL; SEASONS; TABLETS;

EID: 77955813106     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2010.01050.x     Document Type: Article

References (28)

1. Selnes A, Nistad W, Bolle R, Lund E. Diverging prevalence of atopic disorders in Norwegian children. Results from three cross-sectional studies. Allergy 2005 : 60 : 894 9.
2. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008 : 63 (Suppl. 86 8 160.
3. Ait-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J ISAAC Phase Three Study Group. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 2009 : 64 : 123 48.
4. Blaiss MS. Pediatric allergic rhinitis: physical and mental complications. Allergy Asthma Proc 2008 : 29 : 1 6.
5. Majani G, Baiardini I, Giardini A, et al. Health-related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy 2001 : 56 : 313 7.
6. Léger D, Annesi-Maesano I, Carat F, et al. Allergic rhinitis and its consequences on quality of sleep: an unexplored area. Arch Intern Med 2006 : 18 : 1744 8.
7. Stuck BA, Czajkowski J, Hagner AE, Klimek L, Verse T, Hormann K, Maurer JT. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol 2004 : 113 : 663 8.
8. Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol 2007 : 120 : 381 7.
9. Alvarez-Cuesta E, Bousquet J, Canonica GW, et al. Standards for practical allergen-specific immunotherapy. Allergy 2006 : 61 (Suppl. 82 1 20.
10. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007 : 24 : 1.
11. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005 : 60 : 4 12.
12. Cox L. Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations. Curr Allergy Asthma Rep 2007 : 7 : 410 20.
13. Olaguíbel JM, Alvarez Puebla MJ. Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis. J Investig Allergol Clin Immunol 2005 : 15 : 9 16.
14. Wüthrich B, Bucher Ch, Jörg W, et al. Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen. J Investig Allergol Clin Immunol 2003 : 13 : 145 8.
15. Bufe A, Ziegler-Kirbach E, Stoeckmann E, et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004 : 59 : 498 504.
16. Rolinck-Werninghaus C, Wolf H, Liebke C, et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004 : 59 : 1285 93.
17. Wahn U, Tabar A, Kuna P, Halken S, Montagut A, de Beaumont O, le Gall M SLIT Study Group. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009 : 123 : 160 6.
18. Bufe A, Eberle P, Franke-Beckmann E, et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009 : 12 : 167 73.
19. Penagos M, Passalacqua G, Compalati E, Baena-Cagnani CE, Orozco S, Pedroza A, Canonica GW. Metaanalysis of the efficacy of sublingual imunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008 : 133 : 599 609.
20. Larenas-Linnemann D. Sublingual immunotherapy in children: more optimism today. Pediatr Allergy Immunol 2009 : 20 : 399 400.
21. Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007 : 120 : 1338 45.
22. Agostinis F, Foglia C, Landi M, et al. The safety of sublingual immunotherapy with one or multiple pollen allergens in children. Allergy 2008 : 63 : 1637 9.
23. Malling HJ. Immunotherapy as an effective tool in allergy treatment. Allergy 1998 : 53 : 461 72.
24. Passalacqua G, Musarra A, Pecora S, et al. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year). Pediatr Allergy Immunol 2007 : 18 : 58 62.
25. Ibanez MD, Kaiser F, Knecht R, Armentia A, Schopfer H, Tholstrup B, Bufe A. Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children. Pediatr Allergy Immunol 2007 : 18 : 516 22.
26. Horak F, Jaeger S, Worm M, Melac M, Didier A. Implementation of pre-seasonal sublingual imunotherapy with a five-grass pollen tablet during optimal dosage assessment. Clin Exp Allergy 2009 : 39 : 394 400.
27. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 : 108 (Suppl. 5 147 334.
28. Bousquet J, Lockey R, Malling HJ, et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American Academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998 : 81 : 401 5.